Side Events
: RIGHT Foundation
항목 Item | 내용 Content |
| 세션 제목 (Session Title) | Global Health R&D Investments of RIGHT Foundation: Achievements and Opportunities Ahead |
| 주최 기관 (Host Institution) | RIGHT Foundation |
| 날짜 (Date) | Tuesday, 16 September 2025 |
| 시간 (Time) | 14:30 – 18:40 KST |
| 장소 (Venue) | Lilac [3rd Floor] |
| 언어 (Language) | English (Korean-English interpretation service will be provided) |
| 세션 시놉시스 (Session Synopsis) | The session showcases the RIGHT Foundation’s achievements in global health R&D, particularly in developing diagnostics, therapeutics, and vaccines for low- and middle-income countries. Since its founding in 2018, RIGHT has supported 71 projects, with some resulting in products now used in global health. The session aims to present case studies, analyze success factors and challenges, and introduce recent innovations in vaccines, diagnostics, and biologics to explore future collaboration opportunities with Korean partners. |
| 주요 연사 (Main Speakers) | (Speaker 1) Hani Kim, RIGHT - Overview of RIGHT Foundation’s investment portfolio and introduction of the session (Speaker 2) Grace Kim, Noul - A new era in Malaria Control: AI-powered diagnostics for all (Speaker 3) Claude Oeuvray, Merck KGaA/Shinpoong - Collaboration for a novel malaria therapeutic (Speaker 4) Haejin Hu, QuadMedicine, Research Director - New frontier of vaccine delivery technology through Microneedle technology platform (Speaker 5) Ricki Lovett, AbCellera - New frontiers of biologics for infectious disease of pandemic (Speaker 6) Jose Castillo, Quantoom, CEO - Derisked strategies to transition towards RNA vaccine & therapeutics: Common pitfalls & best practices for a successful adoption (Speaker 7) Chandrasekhar Nair (Co-founder/CTO), Molbio - Development in next generation diagnostics for infectious diseases in LMICs, and potential for collaboration with Korean partners (Speaker 8) Paul Kristiansen, CEPI - Diagnostics for pandemic preparedness: Landscape and gap assessment for the 100 Days Mission (Panelist 1) Masao Takahashi, GAVI (Panelist 3) TBD, UNITAID (Panelist 4) Christopher Lim, WHO PAHO |
| 세부 프로그램 (Detailed Program) | [14:30 - 14:35] Opening Remark [14:35 - 15:35] Session 1: Highlights from the RIGHT Investments [15:35 - 16:20] Panel Discussion [16:20 - 16:35] Coffee Break and Photo [16:35 - 17:55] Session 2: Potential partners for Future Collaboration [17:55 - 18:00] Closing Remark |
Program
Venue: Lilac [3rd Floor]
Global Health R&D Investments of RIGHT Foundation: Achievements and Opportunities Ahead 〈 RIGHT Foundation 〉 | |
항목 / Item | 내용 / Content |
세션 제목 / Session Title | Global Health R&D Investments of RIGHT Foundation: Achievements and Opportunities Ahead |
주최 기관 / Host Institution | RIGHT Foundation |
날짜 / Date | Tuesday, 16 September 2025 |
| 시간 / Time | 14:30 - 18:40 KST |
| 장소 / Venue | Lilac [3rd Floor] |
| 언어 / Language | English (Korean-English interpretation service will be provided) |
| 세션 시놉시스 / Session Synopsis | The session showcases the RIGHT Foundation’s achievements in global health R&D, particularly in developing diagnostics, therapeutics, and vaccines for low- and middle-income countries. Since its founding in 2018, RIGHT has supported 71 projects, with some resulting in products now used in global health. The session aims to present case studies, analyze success factors and challenges, and introduce recent innovations in vaccines, diagnostics, and biologics to explore future collaboration opportunities with Korean partners. |
| 주요 연사 / Main Speakers | (Speaker 1) Hani Kim, RIGHT - Overview of RIGHT Foundation’s investment portfolio and introduction of the session(Speaker 2) Grace Kim, Noul - A new era in Malaria Control: AI-powered diagnostics for all (Speaker 3) Claude Oeuvray, Merck KGaA/Shinpoong - Collaboration for a novel malaria therapeutic (Speaker 4) Haejin Hu, QuadMedicine, Research Director - New frontier of vaccine delivery technology through Microneedle technology platform (Speaker 5) Ricki Lovett, AbCellera - New frontiers of biologics for infectious disease of pandemic (Speaker 6) Jose Castillo, Quantoom, CEO - Derisked strategies to transition towards RNA vaccine & therapeutics: Common pitfalls & best practices for a successful adoption (Speaker 7) Chandrasekhar Nair (Co-founder/CTO), Molbio - Development in next generation diagnostics for infectious diseases in LMICs, and potential for collaboration with Korean partners (Speaker 8) Paul Kristiansen, CEPI - Diagnostics for pandemic preparedness: Landscape and gap assessment for the 100 Days Mission (Panelist 1) Masao Takahashi, GAVI (Panelist 3) TBD, UNITAID (Panelist 4) Christopher Lim, WHO PAHO |
| 세부 프로그램 / Detailed Program | [14:30 - 14:35] Opening Remark [14:35 - 15:35] Session 1: Highlights from the RIGHT Investments [15:35 - 16:20] Panel Discussion [16:20 - 16:35] Coffee Break and Photo [16:35 - 17:55] Session 2: Potential partners for Future Collaboration [17:55 - 18:00] Closing Remark |
